Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

Promising New Hope for Refractory Gout: Shanton Pharma Announces Positive Phase 2b Results

Gout, a painful form of inflammatory arthritis, can be a debilitating condition for many. While existing treatments often provide relief, some individuals experience refractory gout, a more severe form that is difficult to manage with conventional therapies. Now, Shanton Pharmaceuticals has announced promising topline data from a Phase 2b clinical trial of their investigational drug, SAP-001, specifically targeting these refractory gout patients.

Understanding Gout and Refractory Gout

Gout is caused by a buildup of uric acid in the blood, leading to the formation of urate crystals in the joints. These crystals trigger inflammation, resulting in intense pain, swelling, and redness, most commonly in the big toe.

Refractory gout occurs when standard urate-lowering therapies (ULTs) like allopurinol or febuxostat fail to adequately reduce uric acid levels or control gout flares. This can be due to various factors, including:

• Kidney issues impacting drug metabolism
• Underlying health conditions
• Failure to achieve target uric acid levels
• Poor adherence to treatment plans

People with refractory gout often experience frequent and severe flares, leading to chronic pain and joint damage. They may also develop tophi, large deposits of urate crystals that can form under the skin around joints and other tissues.

Shanton's SAP-001: A Novel Approach

Shanton's SAP-001 represents a potential new approach to treating gout. According to Dr. Wenfeng Miao, Shanton's CMO, this is the "first successful clinical study with an oral gout drug to treat these refractory patients that normally need to be treated with an intravenous uricase." Unlike current ULTs, which often work by inhibiting uric acid production, SAP-001 utilizes a novel mechanism of action (MOA).

The drug selectively targets a specific kidney transporter involved in uric acid reabsorption. By inhibiting this transporter, SAP-001 increases the amount of uric acid excreted in the urine, thereby lowering uric acid levels in the blood. The Phase 2b trial results reportedly demonstrated "impressive" efficacy across all dosage groups and assessed time points over the six-month treatment period.

What This Means for Gout Patients

The positive results from Shanton's Phase 2b trial offer hope for individuals struggling with refractory gout. The study suggests that SAP-001, with its novel mechanism of action, may provide a much-needed alternative for patients who haven't found adequate relief with existing therapies. The fact that it's an oral medication is also significant, as many current treatments for severe gout require intravenous infusions.

Shanton plans to initiate pivotal studies later this year, marking a significant step towards potentially bringing this new treatment option to patients.

Managing Gout: Lifestyle and Dietary Considerations

While new treatments are on the horizon, lifestyle modifications and dietary changes remain crucial for managing gout and preventing flares. Consider the following:

• Hydration: Drink plenty of water to help flush out uric acid.
• Limit Alcohol: Especially beer and hard liquor, as they can increase uric acid production.
• Reduce Purine Intake: Purines are substances found in certain foods that break down into uric acid. Limit consumption of:
  • Red meat (beef, lamb, pork)
  • Organ meats (liver, kidney)
  • Seafood (especially shellfish, sardines, anchovies)
• Maintain a Healthy Weight: Obesity is associated with higher uric acid levels.
• Eat Cherries: Some studies suggest that cherries and cherry extract may help lower uric acid levels and reduce inflammation.
• Avoid Sugary Drinks: Fructose-sweetened beverages can increase uric acid production.

It's essential to work closely with your doctor to develop a comprehensive gout management plan that includes medication, lifestyle modifications, and dietary changes tailored to your specific needs. New treatments like SAP-001 offer promising avenues for improving the lives of those living with this challenging condition.

Take Control of Your Gout with AI Technology

Managing gout doesn't have to be complicated. GoutSnap AI is a revolutionary mobile app that uses artificial intelligence to analyze your food in real-time and help you make better dietary choices.

Simply snap a photo of your meal, and our AI instantly identifies high-purine foods that could trigger gout attacks. Get personalized recommendations, track your diet history, and prevent flare-ups before they happen.

Key Features:

• 📸 Instant Food Analysis - Take a photo and get immediate purine content information
• 🍽️ Dietary Tracking - Monitor your daily purine intake effortlessly
• 💡 Smart Recommendations - Receive AI-powered suggestions for gout-friendly alternatives
• 📊 Health Insights - Track patterns and identify your personal triggers

There are a few mobile apps for health, diet and manage gout. However, a several thousand of users has concluded that GoutSnap AI is successfully managing their gout with the power of AI.